Pioneering Interventional Solutions for Deep Vein Thrombosis
Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure.
Deep Vein Thrombosis (DVT) is a blood disorder resulting from the formation of a blood clot (thrombus) inside a deep vein of the leg, commonly located in the calf or thigh. DVT occurs when the blood clot either partially or completely blocks the flow of blood in the vein. Patient symptoms include pain, swelling, and discoloration.
Approximately 600,000 new DVT cases are diagnosed each year in the United States with as many as 20 million patients having had a prior DVT. The majority of patients diagnosed with DVT are treated with medication therapy alone. While this therapy reduces the risk of fatal Pulmonary Embolism and further blood clot from forming, the underlying blood clot may remain and result in permanent vein damage and the development of Post Thrombotic Syndrome.
Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company’s Trellis® Peripheral Infusion System and other products. The Trellis system is a unique catheter-based drug delivery device designed to dissolve blood clots in a single, fast procedure.